“To Determine the Frequency of Biochemical Adverse Effects in Patients on Meglumine Antimoniate Treatment for Cutaneous Leishmaniasis”, mfm, vol. 30, no. 9, May 2024, Accessed: Apr. 15, 2026. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/3872